$CARM

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Carisma Therapeutics Inc. (Nasdaq - CARM), Guaranty Bancshares, Inc. (NYSE - GNTY), MRC Global Inc. (NYSE - MRC), Turnstone Biologics Corp. (Nasdaq - TSBX)

BALA CYNWYD, Pa., June 27, 2025 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( jbrodsky@brodskysmith.com ) or Marc Ackerman ( mackerman@brodskysmith.com ) at 855-576-4847.

Original reporting
Benzinga · Globe Newswire
Published Jun 27, 2025, 3:46 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 27, 2025, 4:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CARM
Neutral
high confidence
Mentioned
$CARM
Relevance
6/10
AlphAI data visualization · based on Benzinga
Decision brief

The 30-second read

$CARMNeutralMed
01

Why it matters

The investigations introduce uncertainty, potentially leading to increased volatility, especially for the more relevant tickers.

02

Market read

The news has moderate to low relevance for most tickers, with GBCI and MRC being more impacted due to their higher relevance scores and bullish sentiment.

03

What to watch

Potential for positive resolution or dismissals that could lead to short-term rebounds; also, broader market conditions may overshadow company-specific news.

Relevance 6/10Timing: Immediate to short-term (next 1-2 trading sessions)

Background

The news pertains to investigations involving multiple companies, which could influence investor sentiment and stock prices.

Company-level read

Ticker impact

$CARMNeutralHigh confidence
Context

Low relevance; neutral sentiment and minimal impact due to its low relevance score.

Expected impact

Expected negligible movement, less than 1%.

Evidence & confidence

The low relevance score and neutral sentiment suggest limited immediate trading impact.

Market effects

Potential impact on Life Sciences, Financial Markets, and Mergers & Acquisitions sectors due to ongoing investigations.

Limited regional impact; primarily affecting US-based companies.

Low; investigation news is company-specific and unlikely to influence global markets significantly.

Counterpoint

Investigations may lead to negative sentiment and potential declines if allegations are substantiated, suggesting caution in bullish assumptions.

Key entities

  • Brodsky & Smith

    Legal firm providing shareholder updates and investigation notices.

  • Carisma Therapeutics Inc.

    Subject of investigation, listed on Nasdaq (CARM).

  • Guaranty Bancshares, Inc.

    Subject of investigation, listed on NYSE (GNTY).

  • MRC Global Inc.

    Subject of investigation, listed on NYSE (MRC).

  • Turnstone Biologics Corp.

    Subject of investigation, listed on Nasdaq (TSBX).

Related articles

$RLMed

Ralph Lauren has its wealthy shoppers to thank as retail softens

Ralph Lauren (RL) is outperforming the struggling retail sector due to resilient high-income customers. Bank of America analyst Kendall Toscano maintained a Buy rating and $450 price target, citing steady demand and strong growth in Asia. RL beat Q1 earnings expectations by 7% and is expected to report another strong quarter in November. Shipping costs, up 8%, are less impactful on RL due to fixed pricing agreements.

$MSTRHigh

MSCI rules could drop Strategy, Metaplanet from indexes

MSCI adopted new rules that could remove Strategy (MSTR) and Metaplanet from its indexes. Companies with mainly investment assets may be ineligible. Final decisions are due 11 November. JPMorgan estimates $2.8B outflows if MSTR is excluded. MSTR holds 848,250 BTC, worth $69.67B. MSTR shares are down 72% from their 2024 high.

$AAPLHigh

Japan to invest up to USD21bn in two US chip factories to be run by GlobalFoundries

Japan will invest up to $21bn in two New York chip factories operated by GlobalFoundries, part of a $550bn US investment deal. The US will take a stake, but Japan will provide all capital. GlobalFoundries, majority-owned by Mubadala, will earn fees and license tech. The US will also take a 4% stake in GlobalFoundries, bringing total ownership to ~7%. Initial customers include Renesas and Apple. Japan has already committed over $100bn to US projects.

$TLow

AT&T $177M Data Breach Settlement: Payouts Up to $7,500

AT&T has finalized a $177 million settlement for two 2024 data breaches, with payments up to $7,500 for affected customers. The settlement, approved on October 2, 2026, includes $149 million for the first breach and $28 million for the second. Eligible customers who filed claims by December 18, 2025, will receive payments, with the maximum payout for documented losses. The settlement does not admit wrongdoing by AT&T.